Description:

ODM derived from http://clinicaltrials.gov/show/NCT00264056

Link:

http://clinicaltrials.gov/show/NCT00264056

Keywords:
Versions (2) ▾
  1. 2/23/12
  2. 4/13/14
Uploaded on:

April 13, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00264056 Advanced Metastastic Malignant Melanoma Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age between 18 and 70
histologically proven malignant melanoma with advanced inoperable soft tissue metastases
progressive disease upon systemic first-line chemotherapy
2 or more bidimensionally measurable soft tissue lesions
WHO performance status (ECOG) of 2 or more
life expectancy of 8 weeks and more
prior informed consent
Exclusion Criteria
participation in other therapy studies
pregnancy or breast feeding
concomitant clinically significant infection
cardiac pacemaker or other medical implants, or implants within the hyperthermia treated region (including a safe distance of 5 cm)
lack of physiological heat sensitivity within the hyperthermia treated region (including a safe distance of 5 cm)
Medical Concepts